Myocardial dysfunction in meningococcal septic shock: No clear answer yet

Critical Care Medicine

Volumn 33, Issue 8, 2005, Pages 1884-1886

  Van Deuren, Marcel ^a   Brandtzaeg, Petter ^b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

Circulatory collapse; Meningococcal septic shock; Meningococci; Proinflammatory cytokines

Indexed keywords

CREATINE KINASE MB; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; INTERLEUKIN 8; TROPONIN I; TUMOR NECROSIS FACTOR ALPHA;

CYTOKINE PRODUCTION; DETERIORATION; DISEASE COURSE; EDITORIAL; ESCHERICHIA COLI; HEART MUSCLE CONTRACTILITY; HUMAN; INCIDENCE; MENINGOCOCCOSIS; MYOCARDIAL DISEASE; PRIORITY JOURNAL; SEPTIC SHOCK; VASCULAR DISEASE;

EID: 23844499702     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000174482.51523.96     Document Type: Editorial

References (46)

1. van Deuren M, Brandtzaeg P, van der Meer JWM: Update on meningococcal disease with emphasis on pathogenesis and clinical management. Clin Microbiol Rev 2000; 13: 144-166
2. Brandtzaeg P, Kierulf P, Gaustad P, et al: Plasma endotoxin as a predictor of multiple organ failure and death in systemic meningococcal disease. J Infect Dis 1989; 159: 195-204
3. Ovstebo R, Brandtzaeg P, Brusletto B, et al: Use of robotized DNA isolation and real-time PCR to quantify and identify close correlation between levels of Neisseria meningitidis DNA and lipopolysaccharides in plasma and cerebrospinal fluid from patients with systemic meningococcal disease. J Clin Microbiol 2004; 42:2980-2987
4. Waage A, Brandtzaeg P, Halstensen A, et al: The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome. J Exp Med 1989; 169:333-338
5. Sprong T, Stikkelbroeck N, van der Ley P, et al: Contributions of Neisseria meningitidis LPS and non-LPS to proinflammatory cytokine response. J Leukoc Biol 2001; 70: 283-288
6. Bjerre A, Brusletto B, Ovstebo R, et al: Identification of meningococcal LPS as a major monocyte activator in IL-10 depleted shock plasmas and CSF by blocking the CD14-TLR4 receptor complex. J Endotoxin Res 2003; 9:155-163
7. van Deuren M, van der Ven-Jongekrijg J, Bartelink AK, et al: Correlation between proinflammatory cytokines and antiinflammatory mediators and the severity of disease in meningococcal infections. J Infect Dis 1995; 172:433-439
8. Brandtzaeg P, Osnes L, Øvstebo R, et al: Net inflammatory capacity of human septic shock plasma evaluated by a monocyte-based target cell assay: Identification of interleukin-10 as a major functional deactivator of human monocytes. J Exp Med 1996; 184: 51-60
9. van Deuren M, van der Ven-Jongekrijg J, Vannier E, et al: The pattern of interleukin-1β (IL-1β) and its modulating agents IL-1 receptor antagonist and IL-1 soluble receptor type II in acute meningococcal infections. Blood 1997; 90:1101-1108
10. Frieling JT, van Deuren M, Wijdenes J, et al: Interleukin-6 and its soluble receptor during acute meningococcal infections: Effect of plasma or whole blood exchange. Crit Care Med 1996; 24:1801-1805
11. Brandtzaeg P, Mollnes TE, Kierulf P: Complement activation and endotoxin levels in systemic meningococcal disease. J Infect Dis 1989; 160:58-65
12. Hazelzet JA, de Groot R, van Mierlo G, et al: Complement activation in relation to capillary leakage in children with septic shock and purpura. Infect Immun 1998; 66: 5350-5356
13. Brandtzaeg P, Høgåsen K, Kierulf P, et al: The excessive complement activation in fulminant meningococcal septicemia is predominantly caused by alternative pathway activation. J Infect Dis 1996; 173:647-655
14. Sprong T, Moller AS, Bjerre A, et al: Complement activation and complement-dependent inflammation by Neisseria meningitidis are independent of lipopolysaccharide. Infect Immun 2004; 72:3344-3349
15. Parrillo JE, Burch C, Shelhamer JH, et al: A circulating myocardial depressant substance in humans with septic shock. Septic shock patients with a reduced ejection fraction have a circulating factor that depresses in vitro myocardial cell performance. J Clin Invest 1985; 76:1539-1553
16. Krishnagopalan S, Kumar A, Parrillo JE: Myocardial dysfunction in the patient with sepsis. Curr Opin Crit Care 2002; 8:376-388
17. Thiru Y, Pathan N, Bignall S, et al: A myocardial cytotoxic process is involved in the cardiac dysfunction of meningococcal septic shock. Crit Care Med 2000; 28:2979-2983
18. Pathan N, Sandiford C, Harding SE, et al: Characterization of a myocardial depressant factor in meningococcal septicemia. Crit Care Med 2002; 30:2191-2198
19. Pathan N, Hemingway CA, Alizadeh AA, et al: Role of interleukin 6 in myocardial dysfunction of meningococcal septic shock. Lancet 2004; 363:203-209
20. Monsalve F, Rucabado L, Salvador A, et al: Myocardial depression in septic shock caused by meningococcal infection. Crit Care Med 1984; 12:1021-1023
21. Boucek MM, Boerth RC, Artman M, et al: Myocardial dysfunction in children with acute meningococcemia. J Pediatr 1984; 105: 538-542
22. Hagmolen of ten Have W, Wiegman A, van den Hoek GJ, et al: Life-threatening heart failure in meningococcal septic shock in children: Non-invasive measurement of cardiac parameters is of important prognostic value. Eur J Pediatr 2000; 159:277-282
23. Horisberger JD, Depeursinge F, Portmann L, et al: Dysfunction myocardique aiguë au cours de la septicémie à meningocoques. Schweiz Med Wochenschr 1985; 115: 281-284
24. Berthier JC, Hartemann E: L'incompétence myocardique dans le purpura méningococcique de l'enfant. Presse Med 1987; 16: 519-522
25. Mercier J-C, Beaufils F, Hartmann J-F, et al: Hemodynamic patterns of meningococcal shock in children. Crit Care Med 1988; 16: 27-33
26. Robboy SJ: Atrioventricular-node inflammation-Mechanism of sudden death in protracted meningococcemia. N Engl J Med 1972; 286:1091-1093
27. Suffredini AF, Fromm RE, Parker MM, et al: The cardiovascular response of normal humans to the administration of endotoxin. N Engl J Med 1989; 321:280-287
28. van Bockel EA, Tulleken JE, Muller Kobold AC, et al: Cardiac troponin I release and cytokine response during experimental human endotoxaemia. Intensive Care Med 2003; 29:1598-1600
29. Wu AH: Increased troponin in patients with sepsis and septic shock: Myocardial necrosis or reversible myocardial depression? Intensive Care Med 2001; 27:959-961
30. Carrol ED, Thomson AP, Mobbs KJ, et al: Myositis in children with meningococcal disease: A role for tumour necrosis factor-alpha and interleukin-8? J Infect 2002; 44:17-21
31. Briassoulis G, Narlioglou M, Zavras N, et al: Myocardial injury in meningococcus-induced purpura fulminans in children. Intensive Care Med 2001; 27:1073-1082
32. Binette JP, Montes M, Lee JC: Electron microscopy of muscle biopsies in two cases of meningococcemia. J Med 1972; 3:88-96
33. Wolf RE, Birbara CA: Meningococcal infections at an army training center. Am J Med 1968; 44:243-255
34. Hardman JM, Earle KM: Myocarditis in 200 fatal meningococcal infections. Arch Pathol 1969; 87:318-325
35. Gach O, Lancellotti P, Pierard LA: Acute ST-segment elevation in Neisseria meningitis. Acta Cardiol 2001; 56:327-329
36. Briassoulis G, Kalabalikis P, Thanopoulos V, et al: Non-Q wave acute myocardial infarction in acute meningococcemia in a 10-year-old girl. Pediatr Emerg Care 2000; 16:33-38
37. Detsky AS, Salit IE: Complete heart block in meningococcemia. Ann Emerg Med 1983; 12:391-393
38. del Balzo U, Sakuma I, Levi R: Cardiac dysfunction caused by recombinant human C5A anaphylatoxin: Mediation by histamine, adenosine and cyclooxygenase arachidonate metabolites. J Pharmacol Exp Ther 1990; 253:171-179
39. Yokoyama T, Vaca L, Rossen RD, et al: Cellular basis for the negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian heart. J Clin Invest 1993; 92: 2303-2312
40. Kumar A, Thota V, Dee L, et al: Tumor necrosis factor α and interleukin 1β are responsible for in vitro myocardial cell depression induced by human septic shock serum. J Exp Med 1996; 183:949-958
41. Gulick T, Chung MK, Pieper SJ, et al: Immune cytokine inhibition of beta-adrenergic agonist stimulated cyclic AMP generation in cardiac myocytes. Biochem Biophys Res Commun 1988; 150:1-9
42. Pathan N, Williams EJ, Oragui EE, et al: Changes in the interleukin-6/soluble interleukin-6 receptor axis in meningococcal septic shock. Crit Care Med 2005; 33:1839-1844
43. Frieling JT, van Deuren M, Wijdenes J, et al: Circulating interleukin-6 receptor in patients with sepsis syndrome. J Infect Dis 1995; 171:469-472
44. Derhaschnig U, Bergmair D, Marsik C, et al: Effect of interleukin-6 blockade on tissue factor-induced coagulation in human endotoxemia. Crit Care Med 2004; 32: 1136-1140
45. Remick DG, Bolgos G, Copeland S, et al: Role of interleukin-6 in mortality from and physiologic response to sepsis. Infect Immun 2005; 73:2751-2757
46. van Gameren MM, Willemse PH, Mulder NH, et al: Effects of recombinant human interleukin-6 in cancer patients: A phase I-II study. Blood 1994;84:1434-1441